Glucotrack announces closing of private placement

Rutherford, nj, april 22, 2024 (globe newswire) -- glucotrack, inc. (nasdaq: gctk) (“glucotrack” or the “company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that the company has closed a private placement of securities. the offering included participation by ceo paul v. goode, phd, as well as other members of the company's executive management, board of directors, and existing shareholders.
GCTK Ratings Summary
GCTK Quant Ranking